Table 3.
PWID | Non-IDU | |||||||
---|---|---|---|---|---|---|---|---|
Active patientsa N |
Retainedb N (%) |
On ARTc N (%) |
Virally suppressedd N (%) |
Active patientsa N |
Retainedb N (%) |
On ARTc N (%) |
Virally suppressedd N (%) |
|
2001 | 756 | 517 (68.4 %) | 344 (45.5 %) | 212 (28.0 %) | 1145 | 909 (79.4 %) | 714 (62.4 %) | 478 (41.7 %) |
2002 | 822 | 553 (67.3 %) | 361 (43.9 %) | 248 (30.2 %) | 1253 | 1000 (79.8 %) | 748 (59.7 %) | 526 (42.0 %) |
2003 | 824 | 574 (69.7 %) | 393 (47.7 %) | 271 (32.9 %) | 1311 | 1061 (80.9 %) | 782 (59.6 %) | 559 (42.6 %) |
2004 | 794 | 561 (70.7 %) | 398 (50.1 %) | 282 (35.5 %) | 1344 | 1087 (80.9 %) | 836 (62.2 %) | 652 (48.5 %) |
2005 | 754 | 509 (67.5 %) | 381 (50.5 %) | 308 (40.8 %) | 1345 | 1097 (81.6 %) | 859 (63.9 %) | 683 (50.8 %) |
2006 | 702 | 498 (70.9 %) | 386 (55.0 %) | 320 (45.6 %) | 1347 | 1082 (80.3 %) | 870 (64.6 %) | 740 (54.9 %) |
2007 | 709 | 500 (70.5 %) | 410 (57.8 %) | 347 (48.9 %) | 1412 | 1120 (79.3 %) | 965 (68.3 %) | 829 (58.7 %) |
2008 | 703 | 530 (75.4 %) | 450 (64.0 %) | 394 (56.0 %) | 1422 | 1183 (83.2 %) | 1057 (74.3 %) | 953 (67.0 %) |
2009 | 708 | 566 (79.9 %) | 482 (68.1 %) | 439 (62.0 %) | 1480 | 1257 (84.9 %) | 1131 (76.4 %) | 1049 (70.9 %) |
2010 | 720 | 560 (77.8 %) | 499 (69.3 %) | 456 (63.3 %) | 1547 | 1268 (82.0 %) | 1157 (74.8 %) | 1085 (70.1 %) |
2011 | 696 | 547 (78.6 %) | 493 (70.8 %) | 453 (65.1 %) | 1584 | 1308 (82.6 %) | 1232 (77.8 %) | 1126 (71.1 %) |
2012 | 670 | 551 (82.2 %) | 511 (76.3 %) | 463 (69.1 %) | 1604 | 1297 (80.9 %) | 1237 (77.1 %) | 1139 (71.0 %) |
PWID persons who inject drugs, IDU injection drug use, self-reported transmission risk
“Active” patient defined as having had ≥1 clinical visit, CD4 cell count, or HIV viral load measurement between July 1 of the prior year and June 30 of the calendar year of interest
Retained in care defined as attending ≥2 clinical visits in the Johns Hopkins Medical system >90 days apart between January 1 and December 31 of the calendar year, conditional on being an active patient
On ART defined as having ≥1 antiretroviral prescription for ≥30 days, conditional on being retained in care
Viral suppression defined as having ≥HIV viral load measurement <400 copies/mL, conditional on being on ART